Sandford D. Smith

Companies

• CytokineticsBoard member Mar 7, 2012 to Jan 3, 2024¹
• PALISADE BIO, INC.Board member Jul 31, 2014 to Jul 3, 2019²
• Apricus BiosciencesBoard member Aug 12, 2014 to Jan 8, 2018³
• ARIAD PharmaceuticalsBoard member Jan 19, 2006 to Jul 11, 2008⁴

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• CCytokinetics CYTK18,801 shares⁵$1.2M at $61.95Jan 2, 2024

As of each latest filing. The line shows shares held over time.

Recent filings

• Jan 2, 2024Granted 148 shares at $84.12 of Cytokinetics⁵
• Oct 2, 2023Granted 448 shares at $27.88 of Cytokinetics⁶
• Jul 3, 2023Granted 374 shares at $33.36 of Cytokinetics⁷
• May 10, 2023Granted 5,000 shares of Cytokinetics⁸
• Apr 3, 2023Granted 298 shares at $37.71 of Cytokinetics⁹
• Jan 3, 2023Granted 253 shares at $44.35 of Cytokinetics¹⁰
• Oct 3, 2022Granted 110 shares at $51.11 of Cytokinetics¹¹
• Sep 2, 2022Sold 11,369 shares at $53.97 of Cytokinetics¹²
• Sep 2, 2022Exercised options 2,500 shares at $37.89 of Cytokinetics¹²
• Sep 2, 2022Exercised options 5,834 shares at $24.32 of Cytokinetics¹²
• Sep 2, 2022Exercised options 3,035 shares at $10.68 of Cytokinetics¹²
• Jul 1, 2022Granted 137 shares at $41.00 of Cytokinetics¹³
• May 10, 2022Granted 5,000 shares of Cytokinetics¹⁴
• Apr 1, 2022Granted 146 shares at $38.38 of Cytokinetics¹⁵
• Jan 3, 2022Granted 122 shares at $46.00 of Cytokinetics¹⁶
• Dec 27, 2021Sold 4,124 shares at $45.79 of Cytokinetics¹⁷
• Dec 27, 2021Exercised options 4,124 shares at $15.43 of Cytokinetics¹⁷
• Dec 27, 2021Sold 20,000 shares at $45.79 of Cytokinetics¹⁷
• Dec 27, 2021Exercised options 20,000 shares at $21.61 of Cytokinetics¹⁷
• Dec 27, 2021Sold 4,166 shares at $45.79 of Cytokinetics¹⁷
• Dec 27, 2021Exercised options 4,166 shares at $24.32 of Cytokinetics¹⁷
• Nov 19, 2021Sold 4,032 shares at $41.21 of Cytokinetics¹⁸
• Nov 19, 2021Exercised options 4,032 shares at $12.40 of Cytokinetics¹⁸
• Nov 19, 2021Sold 20,000 shares at $41.21 of Cytokinetics¹⁸
• Nov 19, 2021Exercised options 20,000 shares at $14.25 of Cytokinetics¹⁸